SPONSOR
Lixia Sheng
Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma
Clinical Trials by Lixia Sheng
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology